Results of Annual General Meeting
Released
Released
Announcement PDF
ASX Announcement
30 November 2023
Results of Annual General Meeting
Microba Life Sciences Limited (ASX:MAP) ("Microba" or "the Company") advises that its Annual General Meeting of
Shareholders was held today at 11.00 am Brisbane time.
The resolutions were voted in accordance with the Notice of Annual General Meeting previously advised to the Australian
Securities Exchange, with all resolutions being passed on a poll.
Resolution 7 (Approval of 10% Placement Facility) and Resolution 8 (Renewal of Proportional Takeover Approval Provisions)
were passed by a sufficient majority as special resolutions.
Further information required by section 251AA(2) of the Corporations Act 2001 (Cth) is attached.
This announcement has been authorised for release by the Chair and CEO.
For further information, please contact:
Dr Luke Reid
Chief Executive Officer
E: Luke.Reid@microba.com
Investor / Media Relations
E: investor@microba.com
W: https://ir.microba.com/
Join our Investor Mailing List
About Microba Life Sciences Limited
Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology
for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for
major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers.
Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the
microbiome, health and disease for the development of new health solutions.
not subject to, the registration requirements of the US Securities Act and applicable securities laws of any state or other
jurisdiction of the United States
For more information visit: www.microba.com
Microba encourages all current investors to go paperless by registering their details with the designated registry service
provider, Automic Group.
Microba Life Sciences Ltd ABN 82 617 096 652
Level 10, 324 Queen Street, Brisbane QLD 4000 Australia
T: 1300 974 621 E: investor@microba.com W: microba.com
Disclosure of Proxy Votes
Automic
GPO Box 5193, Sydney, NSW 2001
P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world)
F +61 (0)2 8583 3040 E hello@automic.com.au
ABN 27 152 260 814
Microba Life Sciences Limited
Annual General Meeting
Thursday, 30 November 2023
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
Poll Results (if
applicable)
Proxy Votes
Resolution
Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
1 Adoption of Remuneration Report
P
191,201,203
2 Re-election of Professor Gene Tyson
P
249,172,848
3 Re-election of Mr Richard Bund
P
266,272,848
4 Issue of Director Options to a Related Party under
ASX Listing Rule 10.14 – Ms Jacqueline Fernley
P
191,734,716
5 Authority to issue the Consideration Shares
P
266,272,848
6 Authority to issue the Earn-out Shares
P
266,282,848
7 Approval of 10% Placement Facility
P
266,338,384
8 Renewal of proportional takeover approval
provisions
P
266,328,384
FOR
AGAINST
ABSTAIN
190,721,953
309,000
99.75%
0.16%
249,008,848
0
99.93%
0.00%
265,858,848
250,000
99.84%
0.09%
191,193,466
339,000
99.72%
0.18%
265,756,098
346,500
99.81%
0.13%
265,752,598
360,000
99.80%
0.14%
265,908,134
260,000
99.84%
0.10%
265,906,134
252,000
99.84%
0.09%
69,536
17,169,536
69,536
63,536
69,536
59,536
4,000
14,000
PROXY'S
DISCRETION
FOR
AGAINST
Results
ABSTAIN
170,250
191,103,250
309,000
0.09%
99.84%
0.16%
164,000
250,653,895
0
0.07%
100.00%
0.00%
164,000
267,503,895
250,000
0.06%
99.91%
0.09%
202,250
191,606,763
339,000
0.11%
99.82%
0.18%
170,250
267,407,395
346,500
0.06%
99.87%
0.13%
170,250
267,403,895
360,000
0.06%
99.87%
0.13%
170,250
267,559,431
260,000
0.06%
99.90%
0.10%
170,250
267,557,431
252,000
0.06%
99.91%
0.09%
69,536
OUTCOME
-
17,169,536
Passed
69,536
Passed
63,536
Passed
69,536
Passed
59,536
Passed
4,000
Passed
14,000
Passed
Share your feedback
Discover